Scarica l'app Stockscreener
45.50
2.50%
1.11
Dopo l'orario di chiusura:
45.95
0.45
+0.99%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$44.39
Aprire:
$44.23
Volume 24 ore:
2.88M
Relative Volume:
1.70
Capitalizzazione di mercato:
$2.44B
Reddito:
-
Utile/perdita netta:
$-38.99M
Rapporto P/E:
-15.18
EPS:
-2.9966
Flusso di cassa netto:
$-24.94M
1 W Prestazione:
-1.73%
1M Prestazione:
-11.10%
6M Prestazione:
-46.63%
1 anno Prestazione:
+2.20%
Intervallo 1D:
$43.42
$50.88
Intervallo di 1 settimana:
$43.42
$50.88
Portata 52W:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Nome
Soleno Therapeutics Inc
Settore
Industria
Telefono
650-213-8444
Indirizzo
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Confronta SLNO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
45.50 | 2.38B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-10-07 | Iniziato | Goldman | Buy |
| 2025-08-20 | Iniziato | Wells Fargo | Overweight |
| 2025-06-23 | Iniziato | TD Cowen | Buy |
| 2025-03-05 | Ripresa | Stifel | Buy |
| 2024-12-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-12-02 | Reiterato | Stifel | Buy |
| 2024-09-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-05 | Iniziato | Piper Sandler | Overweight |
| 2024-01-23 | Iniziato | Stifel | Buy |
| 2023-11-21 | Ripresa | Guggenheim | Buy |
| 2020-09-29 | Iniziato | Guggenheim | Buy |
| 2020-01-10 | Iniziato | Craig Hallum | Buy |
| 2019-12-23 | Iniziato | Oppenheimer | Outperform |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
Mostra tutto
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Why Soleno Therapeutics Inc. stock is popular among millennialsWeekly Investment Report & Safe Entry Momentum Stock Tips - ulpravda.ru
Assessing Soleno Therapeutics (SLNO) Valuation After JCEM VYKAT XR Data And FDA Approval - Yahoo Finance
Macro Review: Can Soleno Therapeutics Inc. stock hit record highs againJuly 2025 Short Interest & Expert Curated Trade Setups - ulpravda.ru
Can Soleno Therapeutics Inc. stock hit record highs again2025 Major Catalysts & Smart Investment Allocation Tips - ulpravda.ru
Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the ... - Bluefield Daily Telegraph
Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and - GlobeNewswire
12 Stocks that Will Bounce Back According to Wall Street Analysts - Insider Monkey
Will Soleno Therapeutics Inc. stock deliver strong dividend growthQuarterly Profit Review & Expert Curated Trade Setup Alerts - ulpravda.ru
What technical signals suggest for Soleno Therapeutics Inc. stockOil Prices & Weekly Setup with ROI Potential - ulpravda.ru
Does Soleno Therapeutics Inc. stock trade at a discount to peersWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru
Soleno Therapeutics announces entry into $100M accelerated share repurchase agreement - MSN
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Nasdaq
Is Soleno Therapeutics Inc. stock supported by strong fundamentalsEconomic Data Impact & Market-Leading Growth Rates - ulpravda.ru
Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - FinancialContent
Do You Believe in the Growth Prospects of Soleno Therapeutics (SLNO)? - Insider Monkey
Soleno’s PWS treatment study results published in endocrinology journal By Investing.com - Investing.com India
Soleno’s PWS treatment study results published in endocrinology journal - Investing.com
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unraveling The 140% Upside Potential - DirectorsTalk Interviews
Soleno Therapeutics Announces Publication of Positive Study Results for VYKAT XR in Journal of Clinical Endocrinology and Metabolism - Quiver Quantitative
New PWS hunger drug shows symptoms worsen off treatment in key study - Stock Titan
Allspring Global Investments Holdings LLC Buys 201,983 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Stake Cut by Voya Investment Management LLC - MarketBeat
SLNO News Today | Why did Soleno Therapeutics stock go up today? - MarketBeat
Understanding Momentum Shifts in (SLNO) - Stock Traders Daily
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Risk Hedge: Why analysts recommend Soleno Therapeutics Inc 6XC stock2025 Trading Volume Trends & Community Consensus Trade Alerts - moha.gov.vn
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO) - Business Wire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect - ACCESS Newswire
Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips - ts2.tech
2025-12-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics, Inc. $SLNO Stake Lessened by Harbor Capital Advisors Inc. - MarketBeat
Market Sentiment Around Loss-Making Soleno Therapeutics, Inc. (NASDAQ:SLNO) - 富途牛牛
Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-12-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics Earnings Notes - Trefis
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Soleno Therapeutics Inc. stock affected by interest rate hikesMarket Sentiment Report & Free High Margin Investment Plays - bollywoodhelpline.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2025-12-24 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Soleno Therapeutics (NASDAQ:SLNO) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Soleno Therapeutics Inc (NASDAQ:SLNO) Nasdaq today Biopharma Niche Growth - Kalkine Media
Precision Trading with Soleno Therapeutics Inc. (SLNO) Risk Zones - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation - ACCESS Newswire
Soleno Therapeutics Inc Azioni (SLNO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):